Dyslipidemias in Kidney Disease (eBook)

Adrian Covic, MD, PhD Full Professor of Nephrology Dialysis and Renal Transplantation Unit “C. I. Parhon” University Hospital Iasi, Romania Mehmet Kanbay, MD Associate Professor, Department of Medicine, Division of Nephrology, Kayseri Training and Research Hospital, Melikgazi, Kayseri, Turkey EDGAR V. LERMA, MD, FACP, FASN, FAHA, FASH, FNLA, FNKF Clinical Associate Professor of Medicine Section of Nephrology Department of Medicine University of Illinois at Chicago College of Medicine/ Associates in Nephrology, S.C. Chicago, IL

Prevalence of dyslipidemia in general and in the CKD patient.- Lipid Nephrotoxicity: New Concept for an Old Disease.- Hyperlipidemia a risk factor or protective for progression of CKD in nondibetics.- How lipid lowering agents works: The good, the bad and the ugly.- CVD in CKD - Focus on the dyslipidemia problem.- The CKD patient with dyslipidemia.- Review of Clinical Trials pertaining to dyslipidemias in CKD.- Lifestyle modifications in the management of dyslipidemias in CKD.- Lipid-Lowering Medication Does Adjustments for Reduced Kidney Function.- Non-statins therapies for CKD with dyslipidemia.- Dyslipidemia in dialysis.- Dyslipidemia in the Kidney Transplant Patient.- Dyslipidemia in the Patient with Nephrotic syndrome.- Dyslipidemias in the Pediatric CKD Patient.- Dyslipidemias in the Geriatric CKD Patient.- Dialysis modalities in dyslipidemia.- Review of current guidelines.